EBRD’s Equity Investment into MS Pharma Partners Holding W.L.L.’s Operations in Middle East & North Africa for USD 50 million

Lead party: European Bank for Reconstruction and Development (EBRD) (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: MS Pharma Partners Holding W.L.L (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Algeria, Sudan Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument:…


Lead party: European Bank for Reconstruction and Development (EBRD) (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: MS Pharma Partners Holding W.L.L (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Algeria, Sudan

Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Equity · Deal amount: US$50m

Lead investor/buyer: European Bank for Reconstruction and Development (EBRD) · Investors/buyers: European Bank for Reconstruction and Development (EBRD)

Legal advisers: not identified in the source record.

Source: announced 9 September 2016. Original announcement: ebrd.com.